# Post Operative Adjuvant Therapy De-intensification Trial for Human Papillomavirus-related, p16+ Oropharynx Cancer

> **NCT01687413** · PHASE3 · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 42 (actual)

## Conditions studied

- Oropharyngeal Neoplasms

## Interventions

- **RADIATION:** Intensity-modulated radiation therapy (IMRT)
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT01687413
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-01-10
- **Primary completion:** 2019-10-18
- **Final completion:** 2019-10-18
- **Target enrollment:** 42 (ACTUAL)
- **Why stopped:** Slow accrual and funding issues
- **Last updated:** 2020-11-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01687413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01687413, "Post Operative Adjuvant Therapy De-intensification Trial for Human Papillomavirus-related, p16+ Oropharynx Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01687413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*